Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew H Wilson

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Tissue Engineering. Part A|May 2, 2023
Genome Engineering of Human Urine-Derived Stem Cells to Express Lactoferrin and DeoxyribonucleaseZara Kenigsberg, Richard C Welch, Julie Bejoy, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2009
Optimization of the PiggyBac transposon system for the sustained genetic modification of human T lymphocytesYozo Nakazawa, Leslie E Huye, Gianpietro Dotti, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 21, 2011
PiggyBac-mediated cancer immunotherapy using EBV-specific cytotoxic T-cells expressing HER2-specific chimeric antigen receptorYozo Nakazawa, Leslie E Huye, Vita S Salsman, et al.
American Journal of Physiology. Renal Physiology|June 1, 2026
Urine-derived stem cell extracellular vesicles promote recovery from acute kidney injury in mice and human kidney organoidsEddie S Qian, Julie Bejoy, Richard C Welch, et al.
Nature Biomedical Engineering|February 5, 2025
Evolving adeno-associated viruses for gene transfer to the kidney via cross-species cycling of capsid librariesAlan Rosales, Leo O Blondel, Joshua Hull, et al.
BMC Nephrology|June 22, 2019
Metabolic consequences of cystinuriaLauren E Woodard, Richard C Welch, Ruth Ann Veach, et al.
Molecular Therapy. Methods & Clinical Development|April 25, 2018
Enhanced Expression of Anti-CD19 Chimeric Antigen Receptor in <i>piggyBac</i> Transposon-Engineered T CellsDaisuke Morita, Nobuhiro Nishio, Shoji Saito, et al.
Kidney International|November 14, 2021
Myeloid cyclooxygenase-2/prostaglandin E2/E-type prostanoid receptor 4 promotes transcription factor MafB-dependent inflammatory resolution in acute kidney injuryYu Pan, Shirong Cao, Andrew S Terker, et al.
Cytotherapy|August 11, 2014
Anti-leukemic potency of piggyBac-mediated CD19-specific T cells against refractory Philadelphia chromosome-positive acute lymphoblastic leukemiaShoji Saito, Yozo Nakazawa, Akane Sueki, et al.
Molecular Therapy. Nucleic Acids|August 12, 2025
Partial correction of cystinuria type A in mice via kidney-targeted transposon deliveryLauren E Woodard, Richard C Welch, Anna Menshikh, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Tissue Engineering. Part A|May 2, 2023
Genome Engineering of Human Urine-Derived Stem Cells to Express Lactoferrin and DeoxyribonucleaseZara Kenigsberg, Richard C Welch, Julie Bejoy, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2009
Optimization of the PiggyBac transposon system for the sustained genetic modification of human T lymphocytesYozo Nakazawa, Leslie E Huye, Gianpietro Dotti, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 21, 2011
PiggyBac-mediated cancer immunotherapy using EBV-specific cytotoxic T-cells expressing HER2-specific chimeric antigen receptorYozo Nakazawa, Leslie E Huye, Vita S Salsman, et al.
American Journal of Physiology. Renal Physiology|June 1, 2026
Urine-derived stem cell extracellular vesicles promote recovery from acute kidney injury in mice and human kidney organoidsEddie S Qian, Julie Bejoy, Richard C Welch, et al.
Nature Biomedical Engineering|February 5, 2025
Evolving adeno-associated viruses for gene transfer to the kidney via cross-species cycling of capsid librariesAlan Rosales, Leo O Blondel, Joshua Hull, et al.
BMC Nephrology|June 22, 2019
Metabolic consequences of cystinuriaLauren E Woodard, Richard C Welch, Ruth Ann Veach, et al.
Molecular Therapy. Methods & Clinical Development|April 25, 2018
Enhanced Expression of Anti-CD19 Chimeric Antigen Receptor in <i>piggyBac</i> Transposon-Engineered T CellsDaisuke Morita, Nobuhiro Nishio, Shoji Saito, et al.
Kidney International|November 14, 2021
Myeloid cyclooxygenase-2/prostaglandin E2/E-type prostanoid receptor 4 promotes transcription factor MafB-dependent inflammatory resolution in acute kidney injuryYu Pan, Shirong Cao, Andrew S Terker, et al.
Cytotherapy|August 11, 2014
Anti-leukemic potency of piggyBac-mediated CD19-specific T cells against refractory Philadelphia chromosome-positive acute lymphoblastic leukemiaShoji Saito, Yozo Nakazawa, Akane Sueki, et al.
Molecular Therapy. Nucleic Acids|August 12, 2025
Partial correction of cystinuria type A in mice via kidney-targeted transposon deliveryLauren E Woodard, Richard C Welch, Anna Menshikh, et al.
Pageof 7